Cristiana Scaranna

Bergamo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Preliminary real-world observational data on A8 TouchCare use in adults with type 1 diabetes.

Preliminary real-world observational data on A8 TouchCare use in adults with type 1 diabetes.

Journal: Acta diabetologica

Published: July 10, 2025

Maternal glycaemic levels are associated with incidence of large for gestational age neonates in type 1 diabetic women in pregnancy.

Maternal glycaemic levels are associated with incidence of large for gestational age neonates in type 1 diabetic women in pregnancy.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: February 29, 2024

Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy.

Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy.

Journal: Diabetes technology & therapeutics

Published: October 30, 2023

Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality.

Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 18, 2023

Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.

Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.

Journal: Diabetes technology & therapeutics

Published: March 17, 2023

Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study.

Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study.

Journal: Pharmacological research

Published: June 19, 2022

Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.

Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.

Journal: Acta diabetologica

Published: May 29, 2022

ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide.

ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: July 23, 2020

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study.

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study.

Journal: Diabetes care

Published: June 19, 2020

Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies.

Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies.

Journal: Journal of diabetes

Published: June 16, 2020

Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.

Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study.

Journal: Diabetes technology & therapeutics

Published: October 17, 2019

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Journal: The lancet. Diabetes & endocrinology

Published: August 03, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026